171 results on '"Brinc, Davor"'
Search Results
2. Analytical evaluation and Sigma metrics of 6 next generation chemistry assays on the Abbott Architect system
3. The transfusion-associated dyspnea prospective observation and laboratory assessment study: a protocol for investigating and disambiguating cardiopulmonary and high-grade febrile transfusion reactions in adults
4. Evaluation of hemolysis, lipemia, and icterus interference with common clinical immunoassays
5. Electrophoresis‐Assisted Multilayer Assembly of Nanoparticles for Sensitive Lateral Flow Immunoassay**
6. Discrepant high-sensitivity cardiac troponin I concentrations when measured on the Abbott Alinity ci versus the Abbott Architect system
7. Quantitation of cardiac troponin I in cancer patients treated with immune checkpoint inhibitors: a case-control study
8. Electrophoresis-assisted multilayer assembly of nanoparticles for sensitive lateral flow immunoassay
9. A Diagnostic Dilemma from a Presentation of Shortness of Breath and Chest Pain
10. Evaluation of Three Anti-SARS-CoV-2 Serologic Immunoassays for Post-Vaccine Response
11. Markers of Kidney Injury, Inflammation, and Fibrosis Associated With Ertugliflozin in Patients With CKD and Diabetes
12. Semen biomarker TEX101 predicts sperm retrieval success for men with testicular failure
13. Evaluation of Dried Blood Spot Testing for SARS-CoV-2 Serology Using a Quantitative Commercial Assay
14. Recurring Critical Results and Their Impact on the Volume of Critical Calls at a Tertiary Care Center
15. Changes in Cardiovascular Biomarkers Associated With the Sodium–Glucose Cotransporter 2 (SGLT2) Inhibitor Ertugliflozin in Patients With Chronic Kidney Disease and Type 2 Diabetes
16. Immune Checkpoint Inhibitor-Associated Myocarditis With Persistent Troponin Elevation Despite Abatacept and Prolonged Immunosuppression
17. Performance evaluation of all analytes on the epoc® Blood Analysis System for use in hospital surgical and intensive care units
18. Inaccuracy of Sodium Measurement in Patients with Severe Hypernatremia
19. Defining appropriate utilization of AST testing
20. Mass Spectrometry-Based Assay for Targeting Fifty-Two Proteins of Brain Origin in Cerebrospinal Fluid
21. Validating thyroid-stimulating hormone (TSH) reflexive testing cutpoints in a tertiary care institution
22. Biochemical characterization of human tissue kallikrein 15 and examination of its potential role in cancer
23. Neuronal pentraxin receptor-1 is a new cerebrospinal fluid biomarker of Alzheimer’s disease progression
24. Brain-related proteins as potential CSF biomarkers of Alzheimer's disease: A targeted mass spectrometry approach
25. Targeted Mass Spectrometry-Based Assays for Relative Quantification of 30 Brain-Related Proteins and Their Clinical Applications
26. Biochemical and functional characterization of the human tissue kallikrein 9
27. Electrophoretic Assembly of Antibody–Antigen Complexes Facilitates 1000 Times Improvement in the Limit of Detection of Serological Paper-Based Assay.
28. Preclinical evaluation of a TEX101 protein ELISA test for the differential diagnosis of male infertility
29. Association between Echinococcus granulosus infection and cancer risk – a pilot study in Cyprus
30. Electrophoresis‐Assisted Multilayer Assembly of Nanoparticles for Sensitive Lateral Flow Immunoassay.
31. Quantitation of cardiac troponin I in cancer patients treated with immune checkpoint inhibitors: a case-control study.
32. Identification of brain-enriched proteins in the cerebrospinal fluid proteome by LC-MS/MS profiling and mining of the Human Protein Atlas
33. Therapeutic drug monitoring of mitotane via HPLC-UV: Method development and evaluation
34. Immunocapture-Selected Reaction Monitoring Screening Facilitates the Development of ELISA for the Measurement of Native TEX101 in Biological Fluids*
35. Delineating monoclonal antibody specificity by mass spectrometry
36. A Diagnostic Dilemma from a Presentation of Shortness of Breath and Chest Pain.
37. The bifacial role of helminths in cancer: Involvement of immune and non-immune mechanisms
38. False Biomarker Discovery due to Reactivity of a Commercial ELISA for CUZD1 with Cancer Antigen CA125
39. Evaluation of Three Anti-SARS-CoV-2 Serologic Immunoassays for Post-Vaccine Response.
40. Infection and Cancer: Revaluation of the Hygiene Hypothesis
41. Long-term stability of biochemical markers in pediatric serum specimens stored at −80°C: A CALIPER Substudy
42. Closing the Gaps in Pediatric Laboratory Reference Intervals: A CALIPER Database of 40 Biochemical Markers in a Healthy and Multiethnic Population of Children
43. Optimizing Measurement and Interpretation of the G6PD/Hb Ratio.
44. Transfusion of antibody‐opsonized red blood cells results in a shift in the immune response from the red blood cell to the antibody in a murine model
45. Mechanisms of anti-D action in the prevention of hemolytic disease of the fetus and newborn: what can we learn from rodent models?
46. Mechanisms of anti-D action in the prevention of hemolytic disease of the fetus and newborn
47. Transfusion of IgG-Opsonized Foreign Red Blood Cells Mediates Reduction of Antigen-Specific B Cell Priming in a Murine Model
48. Immunoglobulin G-mediated regulation of the murine immune response to transfused red blood cells occurs in the absence of active immune suppression: implications for the mechanism of action of anti-D in the prevention of haemolytic disease of the fetus and newborn?
49. Intravenous immunoglobulin ameliorates ITP via activating Fc[gamma] receptors on dendritic cells
50. IgG-mediated immunosuppression is not dependent on erythrocyte clearance or immunological evasion: implications for the mechanism of action of anti-D in the prevention of haemolytic disease of the newborn?
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.